Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-02-01
|
| Series: | Cardio-Oncology |
| Online Access: | https://doi.org/10.1186/s40959-024-00205-5 |
| _version_ | 1827326004254736384 |
|---|---|
| author | Jian Chu Lillian Tung Issam Atallah Changli Wei Melody Cobleigh Ruta Rao Steven B. Feinstein Lydia Usha Kathrin Banach Jochen Reiser Tochukwu M. Okwuosa |
| author_facet | Jian Chu Lillian Tung Issam Atallah Changli Wei Melody Cobleigh Ruta Rao Steven B. Feinstein Lydia Usha Kathrin Banach Jochen Reiser Tochukwu M. Okwuosa |
| author_sort | Jian Chu |
| collection | DOAJ |
| first_indexed | 2024-03-07T14:38:26Z |
| format | Article |
| id | doaj.art-093cf72e74ff43ee9aace492fdb7973b |
| institution | Directory Open Access Journal |
| issn | 2057-3804 |
| language | English |
| last_indexed | 2024-03-07T14:38:26Z |
| publishDate | 2024-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Cardio-Oncology |
| spelling | doaj.art-093cf72e74ff43ee9aace492fdb7973b2024-03-05T20:29:53ZengBMCCardio-Oncology2057-38042024-02-011011110.1186/s40959-024-00205-5Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory studyJian Chu0Lillian Tung1Issam Atallah2Changli Wei3Melody Cobleigh4Ruta Rao5Steven B. Feinstein6Lydia Usha7Kathrin Banach8Jochen Reiser9Tochukwu M. Okwuosa10Department of Internal Medicine, Rush University Medical CenterDepartment of Internal Medicine, Rush University Medical CenterDepartment of Internal Medicine, Division of Cardiology, Saint Louis University HospitalDepartment of Internal Medicine, Rush University Medical CenterDepartment of Internal Medicine, Section of Hematology/Oncology, Rush University Medical CenterDepartment of Internal Medicine, Section of Hematology/Oncology, Rush University Medical CenterDepartment of Internal Medicine, Division of Cardiology, Rush University Medical CenterDepartment of Internal Medicine, Section of Hematology/Oncology, Rush University Medical CenterDepartment of Internal Medicine, Division of Cardiology, Rush University Medical CenterDepartment of Internal Medicine, Rush University Medical CenterDepartment of Internal Medicine, Division of Cardiology, Rush University Medical Centerhttps://doi.org/10.1186/s40959-024-00205-5 |
| spellingShingle | Jian Chu Lillian Tung Issam Atallah Changli Wei Melody Cobleigh Ruta Rao Steven B. Feinstein Lydia Usha Kathrin Banach Jochen Reiser Tochukwu M. Okwuosa Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study Cardio-Oncology |
| title | Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study |
| title_full | Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study |
| title_fullStr | Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study |
| title_full_unstemmed | Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study |
| title_short | Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study |
| title_sort | correction soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin treated breast cancer patients a prospective exploratory study |
| url | https://doi.org/10.1186/s40959-024-00205-5 |
| work_keys_str_mv | AT jianchu correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT lilliantung correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT issamatallah correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT changliwei correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT melodycobleigh correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT rutarao correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT stevenbfeinstein correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT lydiausha correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT kathrinbanach correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT jochenreiser correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy AT tochukwumokwuosa correctionsolubleurokinaseplasminogenactivatorreceptorandcardiotoxicityindoxorubicintreatedbreastcancerpatientsaprospectiveexploratorystudy |